Clinical trial

AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

NCT00348699

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE1

Study timeline

Study start (unknown)2006-07-01Date precision: month

Registry last updated2014-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Male Breast Cancerunresolved

Recurrent Breast Cancerunresolved

Recurrent Ovarian Epithelial Cancerunresolved

Recurrent Primary Peritoneal Cavity Cancerunresolved

Recurrent Renal Cell Cancerunresolved

Stage IV Breast Cancerunresolved

Stage IV Ovarian Epithelial Cancerunresolved

Stage IV Primary Peritoneal Cavity Cancerunresolved

Stage IV Renal Cell Cancerunresolved

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

pharmacological studyOTHER

laboratory biomarker analysisOTHER

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00348699 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.